Bristol-Myers Squibb Company Detailed Financials
Full historical quarterly statements
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12.97B | 11.49B | 12.50B | 12.22B | 12.27B | 11.20B | 12.34B | 11.89B |
| Cost of Goods Sold | 3.73B | 3.42B | 4.10B | 3.44B | 3.37B | 3.03B | 4.92B | 5.28B |
| Gross Profit | 9.25B | 8.07B | 8.41B | 8.79B | 8.90B | 8.17B | 7.42B | 6.62B |
| R&D Expenses | 2.96B | 2.65B | 2.59B | 2.53B | 2.58B | 2.26B | 2.79B | 2.35B |
| Operating Expenses | 5.16B | 4.70B | 5.59B | 5.15B | 5.12B | 4.67B | 4.89B | 4.33B |
| Operating Income | 4.09B | 3.37B | 2.81B | 3.64B | 3.77B | 3.50B | 2.53B | 2.29B |
| Other Income / Gains | 0 | -125.0M | -1.34B | -525.0M | -2.00B | -526.0M | -2.36B | -612.0M |
| Net Income | 3.32B | 2.68B | 1.09B | 2.20B | 1.31B | 2.46B | 72.0M | 1.21B |
| EPS (Diluted) | 1.62 | 1.31 | 0.53 | 1.08 | 0.64 | 1.21 | 0.036 | 0.60 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.713 | 0.702 | 0.672 | 0.719 | 0.725 | 0.729 | 0.602 | 0.556 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 352.0M | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 1.58B | 1.50B | 1.98B |
| Selling General And Administrative Expenses | 1.83B | 1.62B | 2.18B | 1.79B | 1.71B | 1.58B | 1.85B | 1.98B |
| Other Expenses | 376.0M | 437.0M | 826.0M | 831.0M | 830.0M | 830.0M | 253.0M | 0 |
| Cost And Expenses | 8.89B | 8.12B | 9.69B | 8.58B | 8.49B | 7.70B | 9.81B | 9.60B |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 407.0M | 411.0M | 432.0M | 480.0M | 485.0M | 494.0M | 496.0M | 505.0M |
| Depreciation And Amortization | 450.0M | 594.0M | 977.0M | 1.01B | 1.01B | 1.01B | 1.88B | 2.59B |
| Ebitda | 4.94B | 4.25B | 2.88B | 4.61B | 3.27B | 4.48B | 2.55B | 4.77B |
| Ebitdaratio | 0.381 | 0.369 | 0.23 | 0.377 | 0.266 | 0.40 | 0.207 | 0.401 |
| Operating Income Ratio | 0.315 | 0.293 | 0.225 | 0.298 | 0.308 | 0.312 | 0.205 | 0.192 |
| Income Before Tax | 4.09B | 3.24B | 1.47B | 3.11B | 1.77B | 2.97B | 175.0M | 1.68B |
| Income Before Tax Ratio | 0.315 | 0.282 | 0.118 | 0.255 | 0.145 | 0.265 | 0.014 | 0.141 |
| Income Tax Expense | 770.0M | 561.0M | 384.0M | 919.0M | 460.0M | 509.0M | 99.0M | 461.0M |
| Net Income Ratio | 0.256 | 0.233 | 0.087 | 0.18 | 0.107 | 0.219 | 0.006 | 0.102 |
| Epsdiluted | 1.62 | 1.31 | 0.53 | 1.08 | 0.64 | 1.20 | 0.035 | 0.60 |
| Weighted Average Shs Out | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B | 2.03B | 2.03B | 2.03B |
| Weighted Average Shs Out Dil | 2.05B | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B | 2.03B |